亚洲 · 区域市场 · CNBC-TV18
RPG Life Sciences Q2: Revenue rises 16.5% to cross ₹200 crore, margin weak
Profit falls YoY to ₹28.22 crore, partly due to an exceptional gain of ₹11.22 crore in the corresponding quarter last year. Domestic formulations business grows 11.6%, ranks as…
在 CNBC-TV18 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.cnbctv18.com)
